**Question:** Mechanism of action of Silodosin:

A. Blocking alpha-1A receptors in the prostate and bladder neck
B. Inhibiting the synthesis of prostaglandins
C. Enhancing the effect of parasympathetic neurotransmitters
D. Promoting the excretion of calcium ions

**Correct Answer:** C. Enhancing the effect of parasympathetic neurotransmitters

**Core Concept:** Silodosin is a selective alpha-1A adrenergic receptor antagonist primarily used in the treatment of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) in men. Alpha-1 adrenergic receptors are involved in regulating the contraction of smooth muscle in the prostate and bladder neck, leading to bladder outlet obstruction and LUTS.

**Why the Correct Answer is Right:** Silodosin's primary mechanism of action involves blocking the alpha-1A adrenergic receptors in the prostate and bladder neck. By doing so, it reduces the contraction of smooth muscle in these areas, leading to improved bladder flow and reduced obstruction.

**Why Each Wrong Option is Incorrect:**

A. Blocking alpha-1A receptors in the bladder neck and prostate is its primary mechanism, not inhibiting prostaglandin synthesis or enhancing sympathetic neurotransmitter effect.
B. Silodosin does not primarily target calcium ions or promote their excretion. Its primary effect is on alpha-1A receptors.
D. While parasympathetic neurotransmitters play a role in the detrusor muscle relaxation, the primary action of Silodosin is on alpha-1A receptors, not directly enhancing the effect of parasympathetic neurotransmitters.

**Clinical Pearl:** Silodosin is a valuable option for the management of LUTS and BPH, as it provides a targeted approach to reducing prostate and bladder neck contraction, resulting in improved urine flow and reduced obstruction.